The Federal Trade Commission (FTC) filed a lawsuit on Tuesday to block Amgen's $27.8 billion acquisition of Horizon Therapeutics. The FTC alleges that the deal would harm competition in the market for autoimmune drugs.
Amgen is a leading pharmaceutical company...
